197 related articles for article (PubMed ID: 37009550)
1. Pityriasis rubra pilaris partially responsive to treatment with upadacitinib: A case report.
Saad M; Spurr A; Lipson J
SAGE Open Med Case Rep; 2023; 11():2050313X231160927. PubMed ID: 37009550
[TBL] [Abstract][Full Text] [Related]
2. Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab.
Hanfstingl K; Pekar-Lukacs A; Motz R; Guenova E; Hoetzenecker W
Case Rep Dermatol; 2018; 10(2):97-100. PubMed ID: 29867429
[TBL] [Abstract][Full Text] [Related]
3. Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris.
Di Stefani A; Galluzzo M; Talamonti M; Chiricozzi A; Costanzo A; Chimenti S
J Dermatol Case Rep; 2013 Mar; 7(1):5-9. PubMed ID: 23580907
[TBL] [Abstract][Full Text] [Related]
4. Late onset pityriasis rubra pilaris type IV treated with low-dose acitretin.
Mota F; Carvalho S; Sanches M; Selores M
Acta Dermatovenerol Alp Pannonica Adriat; 2016; 25(1):15-7. PubMed ID: 27014774
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate treatment in a case of juvenile pityriasis rubra pilaris.
Boyd AH; Polcari IC
Pediatr Dermatol; 2018 Jan; 35(1):e62-e63. PubMed ID: 29044698
[TBL] [Abstract][Full Text] [Related]
6. [Pityriasis rubra pilaris].
Quenan S; Laffitte E
Ann Dermatol Venereol; 2018 Jan; 145(1):50-59. PubMed ID: 29290415
[TBL] [Abstract][Full Text] [Related]
7. Erythrodermic pityriasis rubra pilaris treatment: Two case reports and literature review.
Camela E; Miano C; Di Caterino P; Lo Presti M; De Fata Salvatores G; Fabbrocini G; Megna M
Dermatol Ther; 2020 Nov; 33(6):e14223. PubMed ID: 32820849
[TBL] [Abstract][Full Text] [Related]
8. A Review on Pityriasis Rubra Pilaris.
Wang D; Chong VC; Chong WS; Oon HH
Am J Clin Dermatol; 2018 Jun; 19(3):377-390. PubMed ID: 29302927
[TBL] [Abstract][Full Text] [Related]
9. Management of refractory pityriasis rubra pilaris: challenges and solutions.
Moretta G; De Luca EV; Di Stefani A
Clin Cosmet Investig Dermatol; 2017; 10():451-457. PubMed ID: 29184428
[TBL] [Abstract][Full Text] [Related]
10. Bevacizumab-induced pityriasis rubra pilaris-like eruption.
Brown S; Fletcher JW; Fiala KH
Proc (Bayl Univ Med Cent); 2016 Jul; 29(3):335-6. PubMed ID: 27365893
[TBL] [Abstract][Full Text] [Related]
11. Oral pityriasis rubra pilaris.
Martinez Calixto LE; Suresh L; Matsumura E; Aguirre A; Radfar L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 May; 101(5):604-7. PubMed ID: 16632271
[TBL] [Abstract][Full Text] [Related]
12. Follicular Psoriasis: Differentiation from Pityriasis Rubra Pilaris-An Illustrative Case and Review of the Literature.
Nguyen CV; Farah RS; Maguiness SM; Miller DD
Pediatr Dermatol; 2017 Jan; 34(1):e65-e68. PubMed ID: 27874201
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of severe pityriasis rubra pilaris with secukinumab in a 3-year-old boy.
Xu YH; Dong DD; Lin YF; Wang Q; Huang LM; Shi JQ
Clin Exp Dermatol; 2022 Nov; 47(11):2043-2045. PubMed ID: 35906074
[TBL] [Abstract][Full Text] [Related]
14. A Rare Post-infectious Rash: Pityriasis Rubra Pilaris After COVID-19 Infection.
Duncan P; Flood D; Dietz C
Cureus; 2023 Aug; 15(8):e43810. PubMed ID: 37731438
[TBL] [Abstract][Full Text] [Related]
15. Case report: Area of focus of management of severe pityriasis rubra pilaris by dose optimization of adalimumab biosimilar in combination with acitretin and montelukast.
Heidemeyer K; Seyed Jafari SM; Farnina L; Bossart S; Feldmeyer L; Yawalkar N
Front Med (Lausanne); 2023; 10():1295777. PubMed ID: 38098840
[TBL] [Abstract][Full Text] [Related]
16. Adalimumab for the treatment of pityriasis rubra pilaris: a case report.
Wassef C; Lombardi A; Rao BK
Cutis; 2012 Nov; 90(5):244-7. PubMed ID: 23270195
[TBL] [Abstract][Full Text] [Related]
17. A case of classic adult pityriasis rubra pilaris successfully treated with a combination of acitretin and ustekinumab: A case report.
DeBiasio C; Cyr J; Ayroud Y; Glassman SJ
SAGE Open Med Case Rep; 2022; 10():2050313X221093453. PubMed ID: 35465019
[TBL] [Abstract][Full Text] [Related]
18. Pityriasis rubra pilaris sensitive to narrow band-ultraviolet B light therapy.
Vergilis-Kalner IJ; Mann DJ; Wasserman J; Petronic-Rosic V; Tsoukas MM
J Drugs Dermatol; 2009 Mar; 8(3):270-3. PubMed ID: 19271375
[TBL] [Abstract][Full Text] [Related]
19. Identification of a pathogenic
Nielsen RM; Gram SB; Bygum A
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33431438
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
